Delivery Order SPE2DR25D1022-SPE2DR26FQV2C
- Not listed
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Provocholine 100 mg vials, valued at $27,352.78. The award is structured as a firm fixed price delivery order with no set-aside designation, indicating competitive procurement. The ultimate completion date is set for September 3, 2025, and performance will occur at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The $1,572.10 firm-fixed-price contract is for the supply of Provocholine 100 mg vials, a pharmaceutical product. The delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical for the provision of a comprehensive range of...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a $7,538.38 firm fixed-price delivery order from the Defense Logistics Agency (DLA) on September 17, 2025, for Provocholine inhalation solution in 18-milliliter packs. The contract is set to be completed by September 18, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,650.39 to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Provocholine inhalation solution in 18 mL packs. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's broader pharmaceutical supply relationship with DLA and is scheduled for completion by August 28, 2025. The product will be delivered to the contractor's facility in Conshohocken,...
- The Defense Logistics Agency awarded a $1,809.68 delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Provocholine inhalation solution in 18ML packs. This is a firm fixed price contract with an ultimate completion date of December 12, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's established capability to meet federal...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,601.10 to Amerisourcebergen Drug Corp on January 14, 2026, for the supply of Provocholine Inhalation Solution in 18ML packs. This is a firm fixed-price delivery order with no set-aside designation, structured as a competitive award under the company's larger pharmaceutical supply contract. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of January 15, 2026....
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $3,196.68 for Provocholine inhalation solution in 18mL packs on January 8, 2026, with completion scheduled for January 9, 2026. This competitively awarded, firm fixed-price contract includes no set-aside designation and represents a task order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be supplied from the...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on December 23, 2025, for the supply of Provocholine inhalation solution in 18 mL packs. This is a firm fixed-price delivery order with a ceiling value of $2,663.00 and an ultimate completion date of December 24, 2025. The contract carries no set-aside designation, indicating it was competitively awarded. Performance will be executed from the company's corporate office location in Conshohocken,...
- This delivery order, valued at $4,288.81, awards Amerisourcebergen Drug Corp a contract for Provocholine inhalation solution in 18ML packs. The award, issued by the Defense Logistics Agency on January 16, 2026, with a completion date of January 20, 2026, represents a competitive, firm fixed-price procurement with no set-aside designation. Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Provocholine inhalation solution in an 18ML pack configuration, valued at $10,776.17 under a firm fixed-price contract type. The award, issued on December 15, 2025, with an ultimate completion date of December 16, 2025, represents a non-set-aside competitive award to the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. This delivery order is a child contract executed under...
- SPE2DR25D1022Indefinite Delivery Contract
- SPE2DR25D1022-SPE2DR26FQV2CDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $25,665.16 for the supply of Provocholine 100 mg vials on January 22, 2026, with a completion date of January 23, 2026. This competitive, non-set-aside contract was funded by the Defense Logistics Agency (DLA), which is responsible for supplying medical commodities to the Department of Defense and military healthcare systems. The award operates under a firm fixed-price structure, reflecting the standardized pricing typical of pharmaceutical procurement through DLA's medical supply chain. This delivery order represents a task order issued against AmerisourceBergen Drug Corp's parent company, Cencora, Inc.'s, larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031. Cencora, which operates under the trade name AmerisourceBergen, holds this comprehensive single-award IDC to deliver a broad range of pharmaceutical products and medical supplies globally to support military healthcare programs. The Provocholine delivery fulfills ongoing pharmaceutical supply requirements for military treatment facilities and federal healthcare institutions under this strategic contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $25.7k | 1/21/26 |